Efficacy and marginal cost of treatment with tocilizumab in COVID-19 patientsObservational Study Published on 2023-01-012023-07-11 Journal: Farmacia hospitalaria : órgano oficial de expresión científica de la [Category] COVID19(2023년), [키워드] Asistencia sanitaria delivery of health care Farmacoeconomía Farmacología pharmacoeconomics Pharmacology SARS-CoV-2 Tocilizumab [DOI] 10.1016/j.farma.2022.12.003 PMC 바로가기 [Article Type] Observational Study
[Translated article] Efficacy and marginal cost of treatment with tocilizumab in COVID-19 patientsObservational Study Published on 2023-01-012023-07-11 Journal: Farmacia hospitalaria : órgano oficial de expresión científica de la [Category] COVID19(2023년), [키워드] Asistencia sanitaria delivery of health care Farmacoeconomía Farmacología pharmacoeconomics Pharmacology SARS-CoV-2 Tocilizumab [DOI] 10.1016/j.farma.2022.12.014 PMC 바로가기 [Article Type] Observational Study
The role of cytokines and their antagonists in the treatment of COVID-19 patientsCOVID-19 환자 치료에서 사이토카인과 그 길항제의 역할Review Published on 2023-01-012023-07-09 Journal: Reviews in Medical Virology [Category] COVID19(2023년), [키워드] COVID-19 cytokine SARS-CoV-2 Tocilizumab [DOI] 10.1002/rmv.2372 PMC 바로가기 [Article Type] Review
Successful immunomodulators for the treatment of COVID-19 have opened the pathway for comparative trialsCOVID-19 치료를 위한 성공적인 면역 조절제가 비교 시험의 길을 열었습니다.Comment Published on 2023-01-012023-07-10 Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), [키워드] Baricitinib COVID-19 IL6 inhibitor sarilumab Tocilizumab [DOI] 10.1016/j.cmi.2022.10.016 PMC 바로가기 [Article Type] Comment
Efficacy of Tocilizumab in Management of COVID-19 Patients Admitted to Intensive Care Units: A Multicenter Retrospective Cohort StudyMulticenter Study Published on 2022-12-272023-07-11 Journal: Medicina [Category] COVID19(2023년), [키워드] COVID-19 Cytokine release syndrome in-hospital mortality Tocilizumab [DOI] 10.3390/medicina59010053 PMC 바로가기 [Article Type] Multicenter Study
An EUA for anakinra (Kineret) for COVID-19Article Published on 2022-12-122023-07-11 Journal: The Medical letter on drugs and therapeutics [Category] COVID19(2023년), [키워드] actemra adverse effects Anakinra Baricitinib Corticosteroids COVID-19 Dexamethasone dosage Drug interactions Efficacy lactation Olumiant Pregnancy Remdesivir Safety Tocilizumab Veklury
Drug-induced liver injury following the use of tocilizumab or sarilumab in patients with coronavirus disease 2019Article Published on 2022-12-122023-07-11 Journal: BMC Infectious Diseases [Category] COVID19(2023년), [키워드] Coronavirus disease 2019 (COVID-19) Drug induced liver injury Epidemiology FAERS sarilumab Tocilizumab [DOI] 10.1186/s12879-022-07896-0 PMC 바로가기
Combination therapy with remdesivir and immunomodulators improves respiratory status in COVID-19: A retrospective studyArticle Published on 2022-12-012022-11-15 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 치료제, [키워드] 95% confidence interval Analysis Baricitinib baseline benefit body mass index combination therapy Concomitant contributed control group coronavirus disease COVID-19 COVID-19 patient COVID-19 patients Day Diabetes Mellitus examined faster greater hazard ratio immunomodulator immunomodulators IMPROVE in both group independent investigated median outcome Oxygen administration Patient patients Prognostic factors Remdesivir respiratory recovery retrospective Retrospective study severity single-center study standard treatment supplemental oxygen survival synergistic therapy Tocilizumab treated two group [DOI] 10.1002/jmv.28037 PMC 바로가기
COVID-19 treatments approved in the European Union and clinical recommendations for the management of non-hospitalized and hospitalized patientsArticle Published on 2022-12-012022-11-15 Journal: Annals of Medicine [Category] COVID19(2023년), SARS, 진단, 치료제, [키워드] addition affecting alleviate antiviral medication antiviral medicine approved Baricitinib Care caused Clinical practice clinical recommendations Community courses COVID-19 COVID-19 pandemic COVID-19 patient COVID-19 treatment COVID-19 treatments Critical deaths develop disease disorder drug Dyspnea effective effective drugs European European Medicines Agency European Union Evidence guidelines Health healthcare hospital Hospitalization Hospitalized hospitalized patient hypoxia Intervention involved life-threatening lung involvement management Mild moderate molnupiravir monoclonal antibodies monoclonal antibody Most patient Multiorgan dysfunction New outcome public health recommendation Remdesivir Respiratory failure rheumatoid arthritis SARS-CoV-2 Septic shock severe symptom Symptom the disease the patient therapy Thromboembolism Tocilizumab treat Treatment treatment strategy union vaccination [DOI] 10.1080/07853890.2022.2133162 PMC 바로가기
Baricitinib vs tocilizumab treatment for hospitalized adult patients with severe COVID-19 and associated cytokine storm: a prospective, investigational, real-world studyArticle Published on 2022-12-012023-07-10 Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), [키워드] Baricitinib COVID-19 Cytokine storm SARS-CoV-2 Tocilizumab [DOI] 10.1016/j.ijid.2022.10.037 PMC 바로가기